Characteristic | Stable MM disease (n = 29) | Progressive MM disease (n = 32) |
---|---|---|
Median age, years (range) | 63.96 (39–84) | 63.75 (32–82) |
Gender | Â | Â |
 Male | 66% (19) | 69% (22) |
 Female | 34% (10) | 31% (10) |
Myeloma type | Â | Â |
 IgG | 52% (15) | 50% (16) |
 IgA | 17% (5) | 19% (6) |
 Light chain only | 24% (7) | 15.5% (5) |
 Missing data | 7% (2) | 15.5% (5) |
% MM cells in BM, range | 40% (5–75%) | 40% (10–75%) |
Extramedullary disease | 17% (5) | 9.3% (3) |
Bone lesions | 48.3% (14) | 59.3% (19) |
Number of previous therapies (range) | 2.5 (1–3) | 3.5 (2–4) |